137 related articles for article (PubMed ID: 32279918)
21. Patchy distribution of mucosal lesions in ileal Crohn's disease is not linked to differences in the dominant mucosa-associated bacteria: a study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis.
Vasquez N; Mangin I; Lepage P; Seksik P; Duong JP; Blum S; Schiffrin E; Suau A; Allez M; Vernier G; Tréton X; Doré J; Marteau P; Pochart P
Inflamm Bowel Dis; 2007 Jun; 13(6):684-92. PubMed ID: 17206669
[TBL] [Abstract][Full Text] [Related]
22. Mucosal microbial load in Crohn's disease: A potential predictor of response to faecal microbiota transplantation.
Sarrabayrouse G; Landolfi S; Pozuelo M; Willamil J; Varela E; Clark A; Campos D; Herrera C; Santiago A; Machiels K; Vermeire S; Martí M; Espin E; Manichanh C
EBioMedicine; 2020 Jan; 51():102611. PubMed ID: 31901867
[TBL] [Abstract][Full Text] [Related]
23. Correlation of Biomarker Expression in Colonic Mucosa with Disease Phenotype in Crohn's Disease and Ulcerative Colitis.
Bruno ME; Rogier EW; Arsenescu RI; Flomenhoft DR; Kurkjian CJ; Ellis GI; Kaetzel CS
Dig Dis Sci; 2015 Oct; 60(10):2976-84. PubMed ID: 25956706
[TBL] [Abstract][Full Text] [Related]
24. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
[TBL] [Abstract][Full Text] [Related]
25. Cytokine network in rectal mucosa in perianal Crohn's disease: relations with inflammatory parameters and need for surgery.
Ruffolo C; Scarpa M; Faggian D; Pozza A; Navaglia F; D'Incà R; Hoxha P; Romanato G; Polese L; Sturniolo GC; Plebani M; D'Amico DF; Angriman I
Inflamm Bowel Dis; 2008 Oct; 14(10):1406-12. PubMed ID: 18452203
[TBL] [Abstract][Full Text] [Related]
26. Activation of nuclear factor kappa B in Crohn's disease.
Ellis RD; Goodlad JR; Limb GA; Powell JJ; Thompson RP; Punchard NA
Inflamm Res; 1998 Nov; 47(11):440-5. PubMed ID: 9865503
[TBL] [Abstract][Full Text] [Related]
27. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.
Meijer MJ; Mieremet-Ooms MA; van der Zon AM; van Duijn W; van Hogezand RA; Sier CF; Hommes DW; Lamers CB; Verspaget HW
Dig Liver Dis; 2007 Aug; 39(8):733-9. PubMed ID: 17602907
[TBL] [Abstract][Full Text] [Related]
28. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients.
Bibiloni R; Mangold M; Madsen KL; Fedorak RN; Tannock GW
J Med Microbiol; 2006 Aug; 55(Pt 8):1141-1149. PubMed ID: 16849736
[TBL] [Abstract][Full Text] [Related]
29. IL23R-Protective Coding Variant Promotes Beneficial Bacteria and Diversity in the Ileal Microbiome in Healthy Individuals Without Inflammatory Bowel Disease.
Zakrzewski M; Simms LA; Brown A; Appleyard M; Irwin J; Waddell N; Radford-Smith GL
J Crohns Colitis; 2019 Mar; 13(4):451-461. PubMed ID: 30445599
[TBL] [Abstract][Full Text] [Related]
30. Gene expression alterations in inflamed and unaffected colon mucosa from patients with mild inflammatory bowel disease.
Xu L; Ma L; Lian J; Yang J; Chen S
Mol Med Rep; 2016 Mar; 13(3):2729-35. PubMed ID: 26861951
[TBL] [Abstract][Full Text] [Related]
31. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
Tang R; Yang G; Zhang S; Wu C; Chen M
Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
[TBL] [Abstract][Full Text] [Related]
32. Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease.
Ogino T; Nishimura J; Barman S; Kayama H; Uematsu S; Okuzaki D; Osawa H; Haraguchi N; Uemura M; Hata T; Takemasa I; Mizushima T; Yamamoto H; Takeda K; Doki Y; Mori M
Gastroenterology; 2013 Dec; 145(6):1380-91.e1. PubMed ID: 23993972
[TBL] [Abstract][Full Text] [Related]
33. Importance of TLR9-IL23-IL17 axis in inflammatory bowel disease development: Gene expression profiling study.
Dragasevic S; Stankovic B; Sokic-Milutinovic A; Milosavljevic T; Milovanovic T; Lukic S; Drazilov SS; Klaassen K; Kotur N; Pavlovic S; Popovic D
Clin Immunol; 2018 Dec; 197():86-95. PubMed ID: 30193869
[TBL] [Abstract][Full Text] [Related]
34. Imbalance of Controlled Death in Peripheral Blood Lymphocytes in Crohn's Disease and Ulcerative Colitis.
Dudzińska E; Szymona K; Gil-Kulik P; Chomik P; Świstowska M; Gryzińska M; Kocki J
Medicina (Kaunas); 2019 May; 55(6):. PubMed ID: 31159239
[No Abstract] [Full Text] [Related]
35. Cellular infiltration and cytokine expression correlate with fistulizing state in Crohn's disease.
Naser SA; Romero C; Urbina P; Naser N; Valentine J
Clin Vaccine Immunol; 2011 Sep; 18(9):1416-9. PubMed ID: 21752952
[TBL] [Abstract][Full Text] [Related]
36. Reduced numbers of mucosal DR(int) macrophages and increased numbers of CD103(+) dendritic cells during anti-TNF-α treatment in patients with Crohn's disease.
Dige A; Magnusson MK; Öhman L; Hvas CL; Kelsen J; Wick MJ; Agnholt J
Scand J Gastroenterol; 2016; 51(6):692-9. PubMed ID: 26784676
[TBL] [Abstract][Full Text] [Related]
37. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
38.
Loganes C; Valencic E; Pin A; Marini E; Martelossi S; Naviglio S; De Leo L; Not T; Monasta L; Tommasini A; Marcuzzi A
World J Gastroenterol; 2016 Nov; 22(44):9734-9743. PubMed ID: 27956797
[TBL] [Abstract][Full Text] [Related]
39. Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve and Treated Crohn's Disease.
Maddipatla SC; Kolachala VL; Venkateswaran S; Dodd AF; Pelia RS; Geem D; Yin H; Sun Y; Xu C; Mo A; Kosters A; Yang J; Matthews JD; Ghosn E; Kugathasan S; Qiu P
Inflamm Bowel Dis; 2023 Feb; 29(2):274-285. PubMed ID: 36206201
[TBL] [Abstract][Full Text] [Related]
40. Peptidoglycan Suppresses Phagocytic Activities and Apoptosis of Macrophages in Colonic Mucosa Tissues of Crohn's Disease Patients and In Vitro.
Jing Y; Ran Y; Zhao J; Zhou Z; Zhang J; Qian Y; Yin Z; Zhang M; Lv Z; Zhou L; Wang B
Med Sci Monit; 2018 May; 24():3382-3392. PubMed ID: 29787559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
